![](/img/cover-not-exists.png)
P-252 Interim report: A phase III randomized double blindchemoprevention trial of selenium supplementation in persons with resected stage I non small cell lung cancer
Karp, D., Lee, S., Keller, S., Johnson, D., Kucuk, O., Clamon, G., Marks, R., Johnston, M., Okawara, G., Ruckdeschel, J.Volume:
49
Language:
english
Journal:
Lung Cancer
DOI:
10.1016/s0169-5002(05)80746-9
Date:
July, 2005
File:
PDF, 149 KB
english, 2005